All Sauce from Weekly Sauce:

Up to 60% of women feel some level of fear about giving birth, but a new study suggests that a strong sense of mental well-being could make a difference. Researchers from Robert Gordon University in Scotland and the University of South Australia (UniSA) surveyed 88 women in their third trimester before they attended prenatal classes…  read on >  read on >

The U.S. Food and Drug Administration (FDA)’s top vaccine regulator is returning to his post less than two weeks after the White House had him ousted. Dr. Vinay Prasad will again head the FDA’s Center for Biologics Evaluation and Research, which oversees vaccines and complex treatments for serious diseases, the U.S. Department of Health and…  read on >  read on >

Victims of stalkers appear to have an increased risk of heart disease, a new study says. Women who had been stalked or had obtained a restraining order were more likely to develop heart problems later in life, researchers reported in the journal Circulation. “Stalking is often seen as a form of violence that does not…  read on >  read on >

Nearly 9 out of 10 adults who land in an ER haven’t been fully vaccinated, a new study says. People who came to an emergency department for treatment of minor injuries or illnesses were often unaware of the vaccines available to them, researchers reported Aug. 7 in the Morbidity and Mortality Weekly Report, a publication…  read on >  read on >

A newly refined test can help detect which people with abnormal heart rhythms need treatment for an increased risk of stroke, researchers report. Adding blood tests to an existing risk calculator can help doctors suss out which patients with atrial fibrillation would most benefit from blood thinners, according to findings published Aug. 6 in the…  read on >  read on >

A newly approved implant appears to slow vision loss from a rare and previously untreatable eye disease, researchers report. The eye implant, called ENCELTO, gradually releases proteins that protect light-sensing nerve cells against macular telangiectasia (MacTel) type 2, researchers recently reported in the journal NEJM Evidence. The capsule-sized implant slowed the progression of MacTel in…  read on >  read on >